1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
We're moving to our new format. We begin with a m…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
August 21, 20181h 6mExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.
Topics
medicineoncologyhealthpolicy